IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Aug 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-10

Reporting Person: Hunt Nimrata (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-10	Common Stock	M	769	$67.85	Acquired	8875.2845	Direct
2021-08-10	Common Stock	M	337	$141.60	Acquired	9212.2845	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-10	Incentive Stock Option (right-to-buy)	$67.85	M	769	Disposed	2026-02-13	Common Stock (769)	Direct
2021-08-10	Incentive Stock Option (right-to-buy)	$141.60	M	337	Disposed	2027-02-13	Common Stock (337)	Direct

Footnotes

F1: Grant of option to buy 1,906 shares of Issuer common stock that vested as to 30 shares on February 14, 2018, 365 shares on February 14, 2020, and as to the remainder on February 14, 2021.

F2: Grant of option to buy 1,043 shares of Issuer common stock that vested as to 337 shares on February 14, 2021 and vests as to the remainder on February 14, 2022.

F3: Not applicable.